US STD diagnostics market is growing at a CAGR of around 8.1% during the forecast period. The major aspects that are making considerable contributing towards its high market share include the fact that the country emphasizes more towards increasing the efficiency with the effectiveness of the treatment of various diseases including STDs. Further, the rapidly developed healthcare infrastructure and significant government healthcare spending are promoting R&D of such advanced technology across the country thereby promoting the growth of the US STD diagnostics market.

Visit for Global Sexually Transmitted Diseases (STD) Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size

According to the Research America, the US had spent $182.3 billion in R&D of medical and healthcare and several investments were made by the foundations, industries, Federal agencies and others. The federal agencies had invested more than $35.9 million along with National Institute of Health that comprises $29.6 billion share. There was several spending that the US healthcare and medical had received for research and development R&D activities. 

Several research segments such as healthcare and medical researchers, federal government, academic and research institutes, non-research conducting grant giving entities, as well as state and local government in the US tend to invest heavily in the research of healthcare and medical drugs, medical devices which directly affects the growth of the US STD diagnostics market during the forecast period.

Abbott Laboratories, Inc., Becton, Dickinson and Co., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc. among others are some of the key players operating in the US STD diagnostics market. The STD diagnostics key players are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment.

Research Methodology

The market study of the US STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. US STD Diagnostics Market Research and Analysis by Disease Type
2. US STD Diagnostics Market Research and Analysis by Product
3. US STD Diagnostics Market Research and Analysis by End-user

The Report Covers

• Comprehensive research methodology of the US STD Diagnostics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US STD Diagnostics market.
• Insights about market determinants which are stimulating the US STD Diagnostics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.